Reference 2016-387

REF:            2016-387

Subject:        Treatment for carcinoma and melanoma

          

 

Request:

Please can you supply the following information?

 

The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:

Afatinib (Giotrif)

Ceritinib (Zykadia)

Crizotinib (Xalkori)

Erlotinib (Tarceva)

Gefitinib (Iressa)

Pemetrexed (Alimta)

Nivolumab (Opdivo)

Nintedanib (Vargatef)

 

The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:

Ipilimumab (Yervoy)

Nivolumab (Opdivo)

Ipilimumab AND Nivolumab

Pembrolizumab (Keytruda)

Vemurafenib (Zelboraf)

Vemurafenib AND Cobimetinib

Dabrafenib (Taflinar)

Trametinib (Mekinist)

Dabrafenib AND trametinib

Dacarbazine (DTIC)

 

 

 

Response:

Please can you supply the following information?

 

The number of patients with NON SMALL CELL LUNG CARCINOMA (Stage IIIB/Stage IV) treated in the last 6 months with the following:

Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)

Nintedanib (Vargatef)

The only drug from the list we have used is Dacarbazine. We are unable to break down by indication but we have treated a total of 4 patients in the last 6 months.
The number of patients with METASTATIC MELANOMA Stage IV (advanced or metastatic), treated in the last 6 months with the following:

 

Ipilimumab (Yervoy)

Nivolumab (Opdivo)

Ipilimumab AND Nivolumab
Pembrolizumab (Keytruda)
Vemurafenib (Zelboraf)
Vemurafenib AND Cobimetinib
Dabrafenib (Taflinar)
Trametinib (Mekinist)
Dabrafenib AND trametinib
Dacarbazine (DTIC)

 

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close